Alejandro Quilichini Oliver, MD
Cardiovascular Disease · San Juan, PRNPI 1285081430
Payments from drug & device makers
Across 80 payments — averaging $55.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$577
- Boston Scientific$413
- Amgen$125
- E.r. Squibb & Sons, L.L.C.$120
- PBG Puerto Rico LLC$78
- plus $192 from 6 others
What the payments were for
- Food & beverage$4,37699%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 28 | $2,919 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $577 |
| Boston Scientific | 6 | $413 |
| Amgen | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 7 | $120 |
| PBG Puerto Rico LLC | 4 | $78 |
| Chiesi USA, Inc. | 3 | $43 |
| Novartis | 2 | $41 |
| Merck | 2 | $36 |
| Abbott | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| United Therapeutics Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$764
- COBALT DR MRI SURESCAN$525
- Reveal LINQ$313
- NA$300
- LifeVest$200
- Cobalt$168
- GENERAL - THERAPIES$147
- CareLink$144
- Azure$134
- CryoConsole$133
- Repatha$125
- Crome$121
- WATCHMAN Access System$100
How this compares
$4,424 in reported general payments places this provider in the 60th percentile of 267 cardiovascular disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 34 | $28,291 |
| EliquisApixaban | 37 | $23,602 |
| XareltoRivaroxaban | 25 | $21,730 |
| SynthroidLevothyroxine Sodium | 16 | $1,122 |
| Metoprolol Succinate | 72 | $1,038 |
| Losartan Potassium | 55 | $556 |
| Carvedilol | 36 | $376 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 27 | $374 |
| Atorvastatin Calcium | 46 | $362 |
| Gabapentin | 21 | $320 |
| Amlodipine Besylate | 63 | $309 |
| Enalapril Maleate | 25 | $297 |
| Rosuvastatin Calcium | 19 | $269 |
| Lisinopril | 42 | $250 |
| Hydralazine Hcl | 16 | $229 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in San Juan
- Manuel GuzmanSan Juan$203K
- Sonia VicentySan Juan$69K
- Ramon PereaSan Juan$68K
- Sonia Velazquez-NavarroSan Juan$65K
- Francisco Merced-OrtizSan Juan$54K
- Edwin Rodriguez CruzSan Juan$22K
- Pedro Vargas-OteroSan Juan$15K
- Ricardo ColacioppoSan Juan$14K
- Jose Kareh CorderoSan Juan$13K
- William Borges CancelSan Juan$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.